Small Pharma to announce results of SPL026 Phase IIa trial for Major Depressive Disorder and host conference call on Wednesday, January 25
Small Pharma will host a conference call to discuss the results of the study.
Small Pharma will host a conference call to discuss the results of the study.
Small Pharma To Participate In Upcoming Canaccord Genuity Investor Symposium.
Small Pharma to participate in Jefferies Conference and CNS Summit.
Small Pharma to participate in H.C. Wainwright and Jefferies conferences.
Small Pharma to participate in the H. C. Wainwright 1st Annual Mental Health Conference.
Small Pharma to present at the Jefferies Healthcare Conference in New York City.
Small Pharma to participate in the PSYCH Symposium, London 2022.
Small Pharma to present at the KCSA Psychedelics Virtual Investor Conference.
Small Pharma to present at the 34th Annual Roth Conference in March.
Small Pharma to participate in the 34th Annual Roth Conference in March.